These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 1578493)
21. Influence of plasma protein content and platelet number on the potency of PAF and its antagonist RP 59227 in rabbit platelet preparations. Floch A; Cavero I Br J Pharmacol; 1990 May; 100(1):163-7. PubMed ID: 2372657 [TBL] [Abstract][Full Text] [Related]
22. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets. Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712 [TBL] [Abstract][Full Text] [Related]
23. 4-substituted 2-alkoxytetrahydrofurans as potent and long-lasting PAF antagonists. Carceller E; Merlos M; Giral M; Bartrolí J; García-Rafanell J; Forn J J Med Chem; 1992 Feb; 35(4):676-83. PubMed ID: 1542094 [TBL] [Abstract][Full Text] [Related]
24. [PAF-antagonists with phospholipid structure. 3. Phospholipids with heterocyclane head groups and variations of the phosphorus-nitrogen distance; synthesis, characterization and structure-activity relationship]. Kertscher HP; Ostermann G Pharmazie; 1991 Nov; 46(11):772-4. PubMed ID: 1811226 [TBL] [Abstract][Full Text] [Related]
25. PAF inhibitory activity of diketopiperazines: structure-activity relationships. Shimazaki N; Shima I; Okamoto M; Yoshida K; Hemmi K; Hashimoto M Lipids; 1991 Dec; 26(12):1175-8. PubMed ID: 1819704 [TBL] [Abstract][Full Text] [Related]
26. Prehispanolone, a novel platelet activating factor receptor antagonist from Leonurus heterophyllus. Lee CM; Jiang LM; Shang HS; Hon PM; He Y; Wong HN Br J Pharmacol; 1991 Jul; 103(3):1719-24. PubMed ID: 1657264 [TBL] [Abstract][Full Text] [Related]
27. Analogues of platelet activating factor. 3. Replacement of the phosphate moiety with a sulfonylbismethylene group. Wissner A; Kohler CA; Goldstein BM J Med Chem; 1985 Sep; 28(9):1365-7. PubMed ID: 4032438 [TBL] [Abstract][Full Text] [Related]
28. Design and modeling of new platelet-activating factor antagonists. 2. Synthesis and biological activity of 1,4-bis-(3',4',5'-trimethoxybenzoyl)-2-alkyl and 2-alkyloxymethylpiperazines. Tavet F; Lamouri A; Heymans F; Dive G; Touboul E; Blavet N; Godfroid JJ J Lipid Mediat Cell Signal; 1997 Jan; 15(2):145-59. PubMed ID: 9034961 [TBL] [Abstract][Full Text] [Related]
30. Ex vivo effects of SR 27417, a novel PAF antagonist, on rabbit platelet aggregation and [3H]-PAF binding. Herbert JM; Laplace MC; Maffrand JP J Lipid Mediat; 1992 Feb; 5(1):1-12. PubMed ID: 1327264 [TBL] [Abstract][Full Text] [Related]
31. Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation. Lee LW; Peng HC; Ko WC; Hung WC; Su CH; Lin CH; Huang TF; Yen MH; Sheu JR Eur J Pharmacol; 1999 Jan; 364(2-3):239-46. PubMed ID: 9932729 [TBL] [Abstract][Full Text] [Related]
32. Inhibition by glaucocalyxin A of aggregation of rabbit platelets induced by ADP, arachidonic acid and platelet-activating factor, and inhibition of [3H]-PAF binding. Bin Z; Kun L Thromb Haemost; 1992 Apr; 67(4):458-60. PubMed ID: 1631795 [TBL] [Abstract][Full Text] [Related]
33. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. I. Studies on blood platelets in vitro. Ostermann G; Hofmann B; Kertscher HP; Till U J Lipid Mediat; 1990; 2(1):21-31. PubMed ID: 1966804 [TBL] [Abstract][Full Text] [Related]
34. 2-(3-Pyridyl)thiazolidine-4-carboxamides. 1. Novel orally active antagonists of platelet-activating factor (PAF). Nagaoka H; Hara H; Suzuki T; Takahashi T; Takeuchi M; Matsuhisa A; Saito M; Yamada T; Tomioka K; Mase T Chem Pharm Bull (Tokyo); 1997 Oct; 45(10):1659-64. PubMed ID: 9353894 [TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, and structure-activity relationship studies of novel 1-[(1-acyl-4-piperidyl)methyl]-1H-2- methylimidazo[4,5-c]pyridine derivatives as potent, orally active platelet-activating factor antagonists. Carceller E; Merlos M; Giral M; Balsa D; García-Rafanell J; Forn J J Med Chem; 1996 Jan; 39(2):487-93. PubMed ID: 8558517 [TBL] [Abstract][Full Text] [Related]
36. pA2 values for antagonists of platelet activating factor on aggregation of rabbit platelets. O'Donnell SR; Barnett CJ Br J Pharmacol; 1988 Jun; 94(2):437-42. PubMed ID: 3293683 [TBL] [Abstract][Full Text] [Related]
37. Comparison of the actions of some platelet-activating factor antagonists on platelets and aortic smooth muscles. Teng CM; Yu SM; Ko FN; Chen CC; Wang WC; Chen KY; Huang YL; Huang TF Eur J Pharmacol; 1991 Nov; 205(2):151-6. PubMed ID: 1812005 [TBL] [Abstract][Full Text] [Related]
38. Species differences in platelet aggregation induced by platelet-activating factor (PAF). Shinozaki K; Kawasaki T; Kambayashi J; Sakon M; Shiba E; Ou M; Mori T Methods Find Exp Clin Pharmacol; 1992 Nov; 14(9):663-5. PubMed ID: 1294855 [TBL] [Abstract][Full Text] [Related]